Gene · 369
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ICAT: a novel algorithm to robustly identify cell states following perturbations in single-cell transcriptomes. | Bioinformatics | 2023 | 37086439 | PubTator, text mining | PubMed |
| Cancer-Associated Fibroblasts Are Key Determinants of Cancer Cell Invasion in the Earliest Stage of Colorectal Cancer. | Cell Mol Gastroenterol Hepatol | 2023 | 37085135 | PubTator, text mining | PubMed |
| Whole exome sequencing analysis of canine urothelial carcinomas without BRAF V595E mutation: Short in-frame deletions in BRAF and MAP2K1 suggest alternative mechanisms for MAPK pathway disruption. | PLoS Genet | 2023 | 37079639 | PubTator, text mining | PubMed |
| RAF1 deficiency causes a lethal syndrome that underscores RTK signaling during embryogenesis. | EMBO Mol Med | 2023 | 37066513 | PubTator, text mining | PubMed |
| Osteocalcin modulates parathyroid cell function in human parathyroid tumors. | Front Endocrinol (Lausanne) | 2023 | 37065733 | PubTator, text mining | PubMed |
| Pathological angiogenesis: mechanisms and therapeutic strategies. | Angiogenesis | 2023 | 37060495 | PubTator, text mining | PubMed |
| Integrative epigenome profiling of 47XXY provides insights into whole genomic DNA hypermethylation and active chromatin accessibility. | Front Mol Biosci | 2023 | 37051325 | PubTator, text mining | PubMed |
| Dose-escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF-mutant solid tumors. | Cancer | 2023 | 37042037 | PubTator, text mining | PubMed |
| A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850. | Oncotarget | 2023 | 37036756 | PubTator, text mining | PubMed |
| Analysis of the ERK Pathway Cysteinome for Targeted Covalent Inhibition of RAF and MEK Kinases. | J Chem Inf Model | 2023 | 37022803 | PubTator, text mining | PubMed |
| RAF1 contributes to cell proliferation and STAT3 activation in colorectal cancer independently of microsatellite and KRAS status. | Oncogene | 2023 | 37020037 | PubTator, text mining | PubMed |
| ERK1/2 inhibitors act as monovalent degraders inducing ubiquitylation and proteasome-dependent turnover of ERK2, but not ERK1. | Biochem J | 2023 | 37018014 | PubTator, text mining | PubMed |
| Epithelioid and spindle rhabdomyosarcoma with TFCP2 rearrangement in abdominal wall: a distinctive entity with poor prognosis. | Diagn Pathol | 2023 | 36998041 | PubTator, text mining | PubMed |
| A Rare Single Case of COVID-19-Induced Acute Myocarditis and Encephalopathy Presenting Simultaneously. | Vaccines (Basel) | 2023 | 36992125 | PubTator, text mining | PubMed |
| 2-Aminobenzothiazoles in anticancer drug design and discovery. | Bioorg Chem | 2023 | 36989736 | PubTator, text mining | PubMed |
| 5'-tiRNA-Gln inhibits hepatocellular carcinoma progression by repressing translation through the interaction with eukaryotic initiation factor 4A-I. | Front Med | 2023 | 36973570 | PubTator, text mining | PubMed |
| Strategies to target the cancer driver MYC in tumor cells. | Front Oncol | 2023 | 36969025 | PubTator, text mining | PubMed |
| Structure and RAF family kinase isoform selectivity of type II RAF inhibitors tovorafenib and naporafenib. | J Biol Chem | 2023 | 36963492 | PubTator, text mining | PubMed |
| Rosai-Dorfman Disease: Case Series and Literature Review. | Cureus | 2023 | 36960255 | PubTator, text mining | PubMed |
| RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer. | Nature | 2023 | 36949200 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/369/papers?page=12